Variant report
Variant | nsv514714 |
---|---|
Chromosome Location | chr13:92138511-92142319 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:92115826..92117568-chr13:92136688..92139135,2 | K562 | blood: | |
2 | chr13:92135361..92137135-chr13:92138478..92140147,2 | K562 | blood: | |
3 | chr13:92122838..92124577-chr13:92141726..92143965,2 | K562 | blood: | |
4 | chr13:92135261..92136861-chr13:92137594..92139978,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GPC6-6 | chr13:92139141-92139148 | NONHSAT034696 |
2 | lnc-GPC6-6 | chr13:92138065-92139124 | NONHSAT034696 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150966054 | chr13:92138530-92138531 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs4771835 | chr13:92138595-92138596 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs76688311 | chr13:92138626-92138627 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs568914304 | chr13:92138656-92138657 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs531433510 | chr13:92138738-92138739 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs548336231 | chr13:92138755-92138756 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs116867018 | chr13:92138776-92138777 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs533718800 | chr13:92138780-92138781 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs140764283 | chr13:92138791-92138792 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs570612795 | chr13:92138814-92138815 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs539387227 | chr13:92138837-92138838 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs556135838 | chr13:92138861-92138862 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs576056727 | chr13:92138903-92138904 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs535539210 | chr13:92138909-92138910 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs7996681 | chr13:92138962-92138963 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs555545747 | chr13:92138985-92138986 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs146047561 | chr13:92139008-92139009 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs541220187 | chr13:92139036-92139037 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs183250232 | chr13:92139037-92139038 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs578181962 | chr13:92139073-92139074 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs79380936 | chr13:92139166-92139167 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539810951 | chr13:92139198-92139199 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562449449 | chr13:92139199-92139200 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531295753 | chr13:92139231-92139232 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs548227812 | chr13:92139260-92139261 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535573289 | chr13:92139277-92139278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187344958 | chr13:92139291-92139292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561580148 | chr13:92139327-92139328 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs527387897 | chr13:92139339-92139340 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78029253 | chr13:92139373-92139374 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570671605 | chr13:92139443-92139444 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539346038 | chr13:92139444-92139445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs648167 | chr13:92139448-92139449 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569623452 | chr13:92139468-92139469 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs530520668 | chr13:92139480-92139481 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs647716 | chr13:92139544-92139545 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs572413475 | chr13:92139556-92139557 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147821155 | chr13:92139628-92139629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558044721 | chr13:92139631-92139632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9560815 | chr13:92139644-92139645 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs544042395 | chr13:92139648-92139649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563927394 | chr13:92139658-92139659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535067754 | chr13:92139772-92139773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531853610 | chr13:92139773-92139774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574409969 | chr13:92139783-92139784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535849269 | chr13:92139784-92139785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191979778 | chr13:92139790-92139791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561759167 | chr13:92139828-92139829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527376288 | chr13:92139846-92139847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184583083 | chr13:92139927-92139928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:92133800-92157000 | Weak transcription | Hela-S3 | cervix |
2 | chr13:92138000-92139200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr13:92138000-92139400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr13:92138000-92139600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr13:92138400-92139200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |